Comparing Azilect vs Rasagiline
| Azilect (rasagiline) | Rasagiline |
|
|---|
| Azilect (rasagiline) | Rasagiline |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Parkinson's Disease. Azilect may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Parkinson's Disease. Rasagiline may also be used for purposes not listed in this medication guide. |
Related suggestions Parkinson's Disease
Popular comparisons
|
|||||||||||||||
| More about Azilect (rasagiline) | More about Rasagiline | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Azilect has an average rating of 6.9 out of 10 from a total of 10 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 20% reported a negative effect. |
Rasagiline has an average rating of 6.3 out of 10 from a total of 15 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Azilect side effects |
View all Rasagiline side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Azilect prices |
View all Rasagiline prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
Azilect | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
3 hours |
3 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 518 drugs are known to interact with Azilect:
|
A total of 518 drugs are known to interact with Rasagiline:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
May 16, 2006 |
May 16, 2006 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Sinemet
Sinemet is used to treat symptoms of Parkinson's disease, such as muscle stiffness, tremors ...
Cogentin
Cogentin is used for extrapyramidal reaction, parkinson's disease
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Requip
Requip is used to treat symptoms of Parkinson's disease, such as stiffness, tremors and muscle ...
Mirapex
Mirapex (pramipexole) treats the symptoms of Parkinson's disease and is also used to treat Restless ...
Rytary
Rytary is used to treat symptoms of Parkinson's disease and parkinsonism that may follow carbon ...
Crexont
Crexont (carbidopa and levodopa) is an extended-release capsule that may be used to treat symptoms ...
Exelon
Exelon (rivastigmine) is used to treat dementia caused by Alzheimer's or Parkinson's disease ...
Neupro
Neupro Skin Patches (rotigotine) are used to treat early signs and symptoms of Parkinson's disease ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.